Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trial
0
Authors
Gabriela Tapia-Calle
19 more
Gabriela Tapia-Calle
•
Carla Truyers
17 more
•
Sophie Cambre
Published
January 1, 2025
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
EClinicalMedicine
Topics
Medicine
Epidemiology
Immunology
Internal Medicine
Infectious Diseases
Show all topics
DOI
10.1016/j.eclinm.2024.103016
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
EClinicalMedicine
Topics
Medicine
Epidemiology
Immunology
Internal Medicine
Infectious Diseases
Show all topics
DOI
10.1016/j.eclinm.2024.103016
License
CC-BY
